BridgeBio Pharma, Inc.BBIONASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-569.09M
↓ 34% vs avg
Percentile
P38
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-425.17M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-569.09M | +4.0% |
| 2024 | $-592.97M | +2.4% |
| 2023 | $-607.37M | -18.6% |
| 2022 | $-512.20M | +11.2% |
| 2021 | $-576.63M | -21.5% |
| 2020 | $-474.48M | -78.2% |
| 2019 | $-266.24M | -45.0% |
| 2018 | $-183.66M | -318.8% |
| 2017 | $-43.86M | - |